<script setup lang="ts">
import ELSICardGallery from '@/components/ELSICardGallery.vue'
</script>

<template>
  <div class="flex flex-col bg-slate">
    <div class="w-full flex flex-col items-center px-6">
      <h1 class="font-title text-title-sm lg:text-title text-gold text-center mb-4">
        Ethical, Legal, and Social Issues
      </h1>

      <ELSICardGallery />

      <div class="w-5/6 text-black bg-gray-300 rounded-[3em] p-8 m-4">
        <h1 class="text-title-sm lg:text-title">Doctors</h1>

        <h2 class="text-subtitle-sm lg:text-subtitle">Concerns</h2>

        <p>
            This includes the ethical implications of using a new drug that has not been tested for long-term side effects on patients.
            In order to be able to use the enzymosomes to degrade bacterial biofilms in patients, there will be testing prior to application
            clinically but there may still be ethical considerations and differences between different medical practitioners willingness to
            administer a new drug to patients with little known long-term effects.
        </p>

        <h2 class="text-subtitle-sm lg:text-subtitle mt-4">Concerns</h2>

        <p>
            This includes the ethical implications of using a new drug that has not been tested for long-term side effects on patients.
            In order to be able to use the enzymosomes to degrade bacterial biofilms in patients, there will be testing prior to application
            clinically but there may still be ethical considerations and differences between different medical practitioners willingness to
            administer a new drug to patients with little known long-term effects.
        </p>

        <h2 class="text-subtitle-sm lg:text-subtitle mt-4">Concerns</h2>

        <p>
            This includes the ethical implications of using a new drug that has not been tested for long-term side effects on patients.
            In order to be able to use the enzymosomes to degrade bacterial biofilms in patients, there will be testing prior to application
            clinically but there may still be ethical considerations and differences between different medical practitioners willingness to
            administer a new drug to patients with little known long-term effects.
        </p>
      </div>
    </div>
  </div>
</template>
